Patent details

Basic Information

Publication number:

EP3652183

PCT Application Number:

EP2018068207

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187401575

PCT Publication Number:

WO2019011770

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES

French Title of Invention:

DÉRIVATIVÉS DE 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE

German Title of Invention:

2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVE

SPC Number:

Dates

Filing date:

05/07/2018

Grant date:

08/09/2021

EP Publication Date:

20/05/2020

PCT Publication Date:

17/01/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/09/2021

EP B1 Publication Date:

08/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/07/2022

Expiration date:

05/07/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/09/2021

 

 

Name:

UCB Biopharma SRL

Address:

Allé de la Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:

PROVINS, Laurent

Address:

Belgium (BE)

2

Name:

QUESNEL, Yannick

Address:

Belgium (BE)

3

Name:

CHANTEUX, Hugues

Address:

Belgium (BE)

Priority

Priority Number:

17180432

Priority Date:

10/07/2017

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07D 513/04; A61K 31/433; A61P 25/08;

Publication

European Patent Bulletin

Issue number:

202136

Publication date:

08/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages